Dinutuximab is available in the form of an injection to be administered as an intravenous infusion into the vein. Do not administer dinutuximab as an intravenous push or bolus.
Dosage & When it is to be taken
The recommended dose of dinutuximab 17.5mg/5mL is administered slowly as an intravenous infusion over a period of 10 to 20 hours for 4 days. The drug can be given for a maximum of 5 cycles.
When it is not to be taken (Contraindications)
Dinutuximab is contraindicated in children who are allergic to the drug.
Drug Name : Dinutuximab
Dinutuximab (Unituxin) is a monoclonal antibody which is prescribed for the treatment of a certain type of brain tumor in the nerve cells (neuroblastoma) of children.
